Related Experiment Video

Updated: Jun 30, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 16, 2013

Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia

Simon W Beaven1, Peter Tontonoz

  • 1Department of Medicine, Division of Digestive Diseases, Howard Hughes Medical Institute, University of California, Los Angeles, California 90095-1662, USA. sbeaven@mednet.ucla.edu

Annual Review of Medicine
|January 18, 2006
PubMed

Insights

Dyslipidemia, linked to metabolic syndrome, involves nuclear receptors. Liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are key regulators of lipid, glucose, and inflammatory homeostasis, offering therapeutic targets.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Cardiovascular Disease Research

Background:

  • Dyslipidemia is a primary risk factor for atherosclerosis.
  • It is closely linked to metabolic syndrome, obesity, diabetes, and fatty liver disease.
  • Understanding molecular mechanisms is crucial for developing new therapies.

Purpose of the Study:

  • To review the pivotal role of nuclear hormone receptors in lipid and inflammatory homeostasis.
  • To highlight Liver X Receptor (LXR) and Peroxisome Proliferator-Activated Receptor (PPAR) as key transcriptional regulators.
  • To explore LXR and PPAR signaling networks as potential therapeutic targets for lipid-related diseases.

Main Methods:

  • Literature review of scientific evidence.
  • Focus on molecular mechanisms of nuclear hormone receptors.
  • Analysis of LXR and PPAR roles in metabolic and inflammatory pathways.

Main Results:

  • LXR and PPAR are identified as central transcriptional regulators of lipid metabolism.
  • These receptors also influence glucose homeostasis and inflammation.
  • Evidence supports their significant impact on overall metabolic health.

Conclusions:

  • LXR and PPAR signaling pathways are critical for maintaining lipid, glucose, and inflammatory balance.
  • Targeting LXR and PPAR offers a promising strategy for managing dyslipidemia and associated metabolic diseases.
  • Further research into these nuclear receptors can drive the development of novel therapeutics.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...